Catalog No.
FMD27111
Species reactivity
Human, Mouse, Rabbit
Host species
Rat
Isotype
IgG1, kappa
Clonality
Monoclonal
Conjugation
FITC
Target
Mac-2 antigen, Lectin L-29, LGALS3, Galactose-specific lectin 3, 35 kDa lectin, Galactoside-binding protein, CBP 35, L-31, Gal-3, Laminin-binding protein, Galectin-3, GALBP, IgE-binding protein, Carbohydrate-binding protein 35, MAC2
Concentration
0.5 mg/ml
Endotoxin level
Please contact with the lab for this information.
Accession
P16110
Applications
ELISA, FCM, IF, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.
Stability and Storage
Store at 4°C for 12 months. Protect from light. Do not freeze.
Clone ID
P3
Discovery and affinity maturation of antibody fragments from an unfavorably enriched phage display selection by deep sequencing and machine learning., PMID:40473542
Galectin-3 modulates cellular infectivity and inflammatory response mediated by spike protein of SARS-CoV2., PMID:40253029
Immunohistochemical Expression of HBME-1 in a Spectrum of Thyroid Neoplasms., PMID:39881771
Bcl-2 and galectin-3 expression is associated with recurrence of ameloblastoma., PMID:39802810
Secreted LGALS3BP facilitates distant metastasis of breast cancer., PMID:39789641
Galectin-3 in metabolic disorders: mechanisms and therapeutic potential., PMID:39690058
Nanoparticle biosensors for cardiovascular disease detection., PMID:39681229
Fibrosis mechanisms in systemic sclerosis and new potential therapies., PMID:39656890
Evaluation of galectin-3 and titin in cats with a sarcomeric gene mutation associated with echocardiography., PMID:39619937
Immunohistochemical Study Protocol in Thyroid Pathology., PMID:39579319
The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical Trial., PMID:39547392
Basophils induce protumorigenic cytokines from A549 lung adenocarcinoma via mechanisms requiring IgE, galectin-3, and IL-3 priming., PMID:39432748
Gal-3 blocks the binding between PD-1 and pembrolizumab., PMID:39357979
Enhanced Association of Novel Cardiovascular Biomarkers Fetuin-A and Catestatin with Serological and Inflammatory Markers in Rheumatoid Arthritis Patients., PMID:39337398
The GPI sidechain of Toxoplasma gondii inhibits parasite pathogenesis., PMID:39302131
FOSL1-mediated LINC01566 negatively regulates CD4+ T-cell activation in myasthenia gravis., PMID:39113081
Galectin-3 contributes to pathogenesis of IgA nephropathy., PMID:39084257
PRRSV utilizes MALT1-regulated autophagy flux to switch virus spread and reserve., PMID:39081059
Discovery of crucial cytokines associated with deep vein thrombus formation by protein array analysis., PMID:39026176
Integrated magneto-plasmonic nanostructures-based immunoassay for galectin-3 detection., PMID:39007190
Galectin-3-Binding Protein Inhibits Extracellular Heparan 6-O-Endosulfatase Sulf-2., PMID:38825040
Neutrophils impaired by anti-galectin-3 antibodies elicit inflammation of endothelial cells to aggregate the development of lupus cutaneous vasculitis., PMID:38757282
TLR2-ERK signaling pathway regulates expression of galectin-3 in a murine model of OVA-induced allergic airway inflammation., PMID:38754639
Expression of inducible nitric oxide synthase, nitrotyrosine, eosinophilic peroxidase, eotaxin-3, and galectin-3 in patients with gastroesophageal reflux disease, eosinophilic esophagitis, and in healthy controls: a semiquantitative image analysis of 3,3'-diaminobenzidine-stained esophageal biopsies., PMID:38679488
BAP31 Promotes Angiogenesis via Galectin-3 Upregulation in Neuroblastoma., PMID:38474195
Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma., PMID:38438589
Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids., PMID:38332916
Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2., PMID:38289348
Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3., PMID:38259448
Galectin-3-binding protein inhibits extracellular heparan 6-O-endosulfatse Sulf-2., PMID:38187586
Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis., PMID:38162144
Inhibition of cancer cell‑platelet adhesion as a promising therapeutic target for preventing peritoneal dissemination of gastric cancer., PMID:38020309
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma., PMID:37988837
Enzymatically-derived oligo-carrageenans interact with α-Gal antibodies and Galectin-3., PMID:37985065
Novel immune checkpoint targets: A promising therapy for cancer treatments., PMID:37979454
Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma., PMID:37951919
Galectin-3 does not interact with RNA directly., PMID:37815932
The ligand-dependent suppression of TCR signaling by the immune checkpoint receptor LAG3 depends on the cytoplasmic RRFSALE motif., PMID:37788323
APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints., PMID:37749326
Identifying Similar Allergens and Potentially Cross-Reacting Areas Using Structural Database of Allergenic Proteins (SDAP) Tools and D-Graph., PMID:37737991
Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1., PMID:37701441
Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis., PMID:37652913
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma., PMID:37649401
IgG4-related cholangitis - a mimicker of fibrosing and malignant cholangiopathies., PMID:37598939
Galectin-3 Plays an Important Role in BMP7-Induced Cementoblastic Differentiation of Human Periodontal Ligament Cells by Interacting with Extracellular Components., PMID:37396953
Inhibition of LPS-Induced Inflammatory Response of Oral Mesenchymal Stem Cells in the Presence of Galectin-3., PMID:37371614
Chimera and Tandem-Repeat Type Galectins: The New Targets for Cancer Immunotherapy., PMID:37371482
Antibodies as Models and Tools to Decipher Candida albicans Pathogenic Development: Review about a Unique Monoclonal Antibody Reacting with Immunomodulatory Adhesins., PMID:37367572
TNF-α promotes CXCL-1/8 production in keratinocytes by downregulating galectin-3 through NF-κB and hsa-miR-27a-3p pathway to contribute psoriasis development., PMID:37358143
Galectin-3 Mediates NETosis and Acts as an Autoantigen in Systemic Lupus Erythematosus-Associated Diffuse Alveolar Haemorrhage., PMID:37298447
For research use only. Not for human or drug use.
